Health Insurance Administration in the same year also found that the annual cost of chronic ischemic heart disease reached 12.266 billion yuan. Based on the above, it can be seen that the total cost of health insurance for diabetes, chronic ischemic heart disease and chronic kidney disease is quite considerable, which shows that the prevention and treatment of diabetes is urgent! Want to reduce your health care burden? Diabetics should protect their organs as soon as possible to control blood sugar and prevent comorbidities In view of this,
in order to reduce the burden of health care, it is very important to intervene in the medication and treatment of diabetes patients as soon as possible to avoid the occurrence of subsequent comorbidities caused by uncontrolled blood sugar. Dr. Li Hongyuan pointed out, "In recent years, the international concept of diabetes treatment has changed dramatically. It is no longer simply controlling blood sugar, but also protecting organs as soon as possible." The latest Illustrator Art Work treatment guidelines published by the American Diabetes Association (ADA) suggest that physicians should assess the risk of comorbidities such as cardiovascular disease and kidney disease from the early stage of treatment of diabetic patients,
while incretin (GLP-1 RA) and glycemic drugs (SGLT2 inhibitory) drug) is the drug recommended by the guidelines to give priority to use. Incretin not only stabilizes blood sugar and body weight, research: it can also reduce the risk of cardio-renal comorbidities Among them, incretin has excellent performance in stabilizing blood sugar, weight loss, and alleviating comorbidities.